Facciuto Marcelo E, Rodriguez-Davalos Manuel I, Singh Manoj K, Rocca Juan P, Rochon Caroline, Chen Wei, Katta Umadevi S, Sheiner Patricia A
Westchester Medical Center, New York Medical College, Valhalla, USA.
Surgery. 2009 Apr;145(4):406-10. doi: 10.1016/j.surg.2008.12.004. Epub 2009 Feb 14.
Meso-Rex bypass is used to treat patients with clinically important extrahepatic portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is used to bypass the portal blood circulation from the superior mesenteric vein to the left portal vein. Other vascular conduits have included the autogenous saphenous vein, splenic vein, right gastroepiploic vein, and inferior mesenteric vein.
A total of 20 umbilical veins with attached livers were harvested from 20 deceased liver donors. Umbilical veins were dilated mechanically and checked for patency and communication with the left portal vein. Vein length and diameter after dilatation were recorded. Cross-sections of 15 recanalized umbilical veins were processed by routine histologic examination and stained with hematoxylin and eosin, as well as processed by immunohistochemistry for CD31 and factor VIII antigens. Subsequently, 3 children with EHPVO underwent this modified meso-Rex bypass using the umbilical vein as a vascular conduit.
The mean length of harvested umbilical veins was 15 cm (range, 7-21); the mean length of recanalized and usable umbilical veins was 10 cm (range, 5-15). Recanalization was successful in 16 (80%) of the 20 donor umbilical veins. The mean diameter of the umbilical veins after serial dilatation and recanalization was 1.2 cm (range, 1-2). In 11 (73%) of the 15 recanalized vein specimens, the lumen was lined by endothelial cells. In 2 children, the vascular conduit was constructed entirely with native umbilical vein. In the remaining child, 3 cm of umbilical vein was preserved and anastomosed to a mobilized inferior mesenteric vein due to inadequate length. All 3 children had patent bypass and resolution of clinical manifestations of portal hypertension at a mean follow-up of 21 months.
Meso-Rex bypass may prove to be a definitive treatment for patients with EHPVO. The use of native umbilical vein as a vein conduit achieved decompression of the splanchnic venous system and should be considered a natural alternative to other interposition vein grafts.
肠系膜上静脉-左门静脉分流术(Meso-Rex旁路手术)用于治疗具有临床重要意义的肝外门静脉阻塞(EHPVO)患者。通常,采用自体左颈内静脉移植物来建立从肠系膜上静脉到左门静脉的门静脉血液循环旁路。其他血管导管还包括自体大隐静脉、脾静脉、胃网膜右静脉和肠系膜下静脉。
从20名已故肝脏供体获取20条带有肝脏的脐静脉。对脐静脉进行机械扩张,并检查其通畅性以及与左门静脉的连通情况。记录扩张后静脉的长度和直径。对15条再通的脐静脉进行横断面常规组织学检查,并用苏木精和伊红染色,同时进行CD31和因子VIII抗原的免疫组织化学检测。随后,3例EHPVO患儿接受了这种使用脐静脉作为血管导管的改良Meso-Rex旁路手术。
所获取脐静脉的平均长度为15厘米(范围7 - 21厘米);再通且可用的脐静脉平均长度为10厘米(范围5 - 15厘米)。20条供体脐静脉中有16条(80%)再通成功。经系列扩张和再通后脐静脉的平均直径为1.2厘米(范围1 - 2厘米)。15条再通静脉标本中有11条(73%)管腔内衬有内皮细胞。2例患儿的血管导管完全由天然脐静脉构建。在其余1例患儿中,由于长度不足,保留了3厘米脐静脉并与游离的肠系膜下静脉进行吻合。所有3例患儿的旁路均通畅,平均随访21个月时门静脉高压的临床表现得到缓解。
Meso-Rex旁路手术可能被证明是EHPVO患者的确定性治疗方法。使用天然脐静脉作为静脉导管实现了内脏静脉系统减压,应被视为其他间置静脉移植物的自然替代方案。